About XtalPi
XtalPi leverages AI, quantum physics, and automation to speed up drug discovery and materials research.
Mission & Story
Mission
Our mission is to democratize access to data-driven discovery tools to accelerate the molecular R&D process.
Clinical Focus
Medical conditions and clinical areas addressed by XtalPi.
Who It Serves
Milestones & Awards
Recent Milestones
First-ever demonstration of SARM1's mechanism using Cryo-EM (2024), Novel GPX4 hits discovery (2024), Nirmatrelvir polymorph research (2024)
Key Partnerships
Social & Media
Follow on
Latest Updates
XtalPi and VISEN Pharmaceuticals Enter Strategic Partnership to Co-Develop Innovative Endocrine Therapies for a Multi-Billion Dollar Market
XtalPi Convenes Global Experts to Shape the Future of Molecular Glue Drug Discovery: From Serendipity to Precision
XtalPi-Powered ReviR Therapeutics Secures Additional NMPA Clinical Approval for “AI+RNA” Rare Disease Pipeline RTX-117
XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
Leading Automation Capabilities of XtalPi Recognized by Global Chemical Giant – Successful Launch of Advanced Automated Workstation at BASF
Company Details
- Founded
- 2015
- Headquarters
- Cambridge, MA, USA
- Employees
- 1254
- Stage
- public
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Similar Companies in this Market
View all 64 →
A2A Pharmaceuticals
AI-driven pharmaceutical company focused on discovering and developing novel drug candidates using computational biology and machine learning.
AbCellera
AbCellera uses AI and machine learning to discover and develop antibody-based therapeutics and vaccines.
Absci
Absci uses AI-powered computational biology and machine learning to accelerate drug discovery and optimize therapeutic proteins and antibodies.
Adaptyv Bio
11-50 employees
Adaptyv Bio operates the world's fastest protein validation lab, providing automated experimental testing services for AI-designed proteins. The company enables protein engineers to validate binding, expression, and thermostability of novel protein designs through a fully automated platform with 3-week turnaround times.
Aitia
Aitia is a drug discovery and development company leveraging AI and computational biology to identify novel therapeutic targets and accelerate drug development.
Anagenex
Anagenex is a biotechnology company focused on drug discovery and development. The company appears to operate in the pharmaceutical research space, though specific details about their technology platform, therapeutic areas, and target markets are not available from the provided content.
Aqemia
Aqemia is a drug discovery company advancing next-generation medicines using generative AI and deep physics. The company combines AI-augmented discovery with computational chemistry to develop novel therapeutics at scale.
Arctoris
51-200 employees
Arctoris is a Partnership Research Organisation (PRO) providing automated wet lab biology R&D and data generation services for biotech, techbio, and pharma companies through its Ulysses® robotic platform.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.